OSBPL2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.591180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.723160E-01
Normal-vs-Stage2
1.471990E-01
Normal-vs-Stage3
6.999000E-01
Normal-vs-Stage4
7.564300E-02
Stage1-vs-Stage2
8.205800E-01
Stage1-vs-Stage3
3.655800E-01
Stage1-vs-Stage4
7.188600E-01
Stage2-vs-Stage3
2.213200E-01
Stage2-vs-Stage4
8.564400E-01
Stage3-vs-Stage4
2.574000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.722190E-01
Normal-vs-AfricanAmerican
1.059360E-01
Normal-vs-Asian
2.568400E-02
Caucasian-vs-AfricanAmerican
8.338000E-01
Caucasian-vs-Asian
3.758400E-01
AfricanAmerican-vs-Asian
7.462800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.496790E-01
Normal-vs-Female
1.641220E-01
Male-vs-Female
3.805700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.395400E-01
Normal-vs-Age(41-60Yrs)
8.934300E-02
Normal-vs-Age(61-80Yrs)
2.130400E-01
Normal-vs-Age(81-100Yrs)
1.368000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.737200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.858000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.631200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.653000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.811600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.580200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.207200E-01
Normal-vs-Daily Drinker
1.906240E-01
Normal-vs-Weekly Drinker
3.386600E-01
Normal-vs-Occasional Drinker
5.983600E-02
Normal-vs-Social Drinker
1.600160E-01
Non Drinker-vs-Daily Drinker
5.138200E-01
Non Drinker-vs-Weekly Drinker
9.961600E-01
Non Drinker-vs-Occasional Drinker
3.302200E-01
Non Drinker-vs-Social Drinker
9.976800E-01
Daily Drinker-vs-Weekly Drinker
6.327400E-01
Daily Drinker-vs-Occasional Drinker
8.125600E-01
Daily Drinker-vs-Social Drinker
5.751800E-01
Weekly Drinker-vs-Occasional Drinker
4.615400E-01
Weekly Drinker-vs-Social Drinker
9.983400E-01
Occasional Drinker-vs-Social Drinker
3.538400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.510200E-02
Normal-vs-Grade 2
1.478280E-02
Normal-vs-Grade 3
2.987700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.957620E-01
Grade 1-vs-Grade 3
6.117700E-02
Grade 1-vs-Grade 4
5.510200E-02
Grade 2-vs-Grade 3
2.121600E-01
Grade 2-vs-Grade 4
1.478280E-02
Grade 3-vs-Grade 4
2.987700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.165000E-01
Normal-vs-NonDiabetic
9.879700E-02
Diabetic-vs-NonDiabetic
8.171900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.834350E-02
Normal-vs-NoPancreatitis
2.088600E-01
Pancreatitis-vs-NoPancreatitis
2.098800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.077600E-01
Normal-vs-N1
1.832220E-01
N0-vs-N1
3.434800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.7677000004096E-07
Normal-vs-TP53-NonMutant
2.758300E-04
TP53-Mutant-vs-TP53-NonMutant
5.197500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
